Form 4: Jazz Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Renee D Gala, President & CEO and a Director of Jazz Pharmaceuticals plc, sold 2,000 shares of common stock on October 6, 2026 for $236.40 per share.
Summary
- Open-market sale: disposed of 2,000 Ordinary Shares at $236.40 ($472,800) on October 6, 2026; holds 141,394 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $472,800 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Renee D Gala — Director, Officer (President & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Open-market sale | Ordinary Shares | 2,000 | $236 | $472.8K | 141,394 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Open-market sale (2,000 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, bearish, Renee D Gala
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.